Raymond de Vre
Chairman bij PolyPeptide Laboratories A/S
Vermogen: 554 597 $ op 31-03-2024
Profiel
Raymond de Vre is currently the Chairman at PolyPeptide Laboratories A and a Director at Aurigene Discovery Technologies Ltd.
He was previously the Chief Executive Officer at PolyPeptide Group AG from 2021 to 2023 and a Partner at McKinsey & Co., Inc. from 2004 to 2011.
Dr. de Vre holds a doctorate degree from Stanford University and a graduate degree from Université Libre de Bruxelles.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
POLYPEPTIDE GROUP AG
0.05% | 31-12-2022 | 16 486 ( 0.05% ) | 554 597 $ | 31-03-2024 |
Actieve functies van Raymond de Vre
| Bedrijven | Functie | Begin |
|---|---|---|
Aurigene Discovery Technologies Ltd.
 Aurigene Discovery Technologies Ltd. BiotechnologyHealth Technology Aurigene Discovery Technologies Ltd. operates as biotechnology company. It offers research services such as integrated research and stand-alone research. The company is headquartered in Bangalore, India. | Director/Board Member | - |
PolyPeptide Laboratories A/S
 PolyPeptide Laboratories A/S Chemicals: SpecialtyProcess Industries PolyPeptide Laboratories A/S manufactures polypeptides and custom peptide synthesis. It offers custom research grade, good manufacturing practice-grade, therapeutic, generic and radiolabeled peptides. The company was founded in 2004 and is headquartered in Hillerod, Denmark. | Chairman | - |
Eerdere bekende functies van Raymond de Vre
| Bedrijven | Functie | Einde |
|---|---|---|
| POLYPEPTIDE GROUP AG | Chief Executive Officer | 30-01-2023 |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Corporate Officer/Principal | 01-01-2011 |
Opleiding van Raymond de Vre
| Stanford University | Doctorate Degree |
| Université Libre de Bruxelles | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| POLYPEPTIDE GROUP AG | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Commercial Services |
Aurigene Discovery Technologies Ltd.
Aurigene Discovery Technologies Ltd. BiotechnologyHealth Technology Aurigene Discovery Technologies Ltd. operates as biotechnology company. It offers research services such as integrated research and stand-alone research. The company is headquartered in Bangalore, India. | Health Technology |
PolyPeptide Laboratories A/S
PolyPeptide Laboratories A/S Chemicals: SpecialtyProcess Industries PolyPeptide Laboratories A/S manufactures polypeptides and custom peptide synthesis. It offers custom research grade, good manufacturing practice-grade, therapeutic, generic and radiolabeled peptides. The company was founded in 2004 and is headquartered in Hillerod, Denmark. | Process Industries |
